amgen announces positive topline phase 3 results for bemarituzumab in fibroblast growth factor receptor 2b (fgfr2b) positive first-line gastric cancer Jun. 30, 2025 9:00 AM ET Amgen Inc. (AMGN) ...

amgen and kyowa kirin provide top-line results from rocatinlimab phase 3 ignite study in adults with moderate to severe atopic dermatitis. mar. 08, 2025 6:00 am et kirin holdings company, ...

Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average ®, and it is also part of the Nasdaq-100 Index ®, which includes the largest and most innovative non-financial ...

THOUSAND OAKS, Calif., Feb. 28, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will present at the 45th Annual TD Cowen Health Care Conference at 9:10 a.m. ET on Wednesday, March 5, 2025. Jay Bradner ...

Amgen's Karol Speight discusses the trends dictating careers in the forensic analysis and wider biopharma industries.

Biotech companies must develop new medicines to remain successful since older ones eventually encounter patent cliffs and face generic or biosimilar competition. However, launching new drugs is no ...

The jury after just over half a day of deliberations found Amgen Inc. liable on 10 of the 11 claims in the complaint, including monopolization and unreasonable restraint of trade in violation of ...

Amgen (AMGN) closed at $273.68 in the latest trading session, marking a -1.3% move from the prior day. This change was narrower than the S&P 500's 2.36% loss on the day. Meanwhile, the Dow lost 2. ...

In the latest trading session, Amgen (AMGN) closed at $318.65, marking a +0.47% move from the previous day. The stock outpaced the S&P 500's daily loss of 1.07%. Elsewhere, the Dow lost 0.62% ...

Biotech giant Amgen (AMGN 0.48%) has had a harsh reminder of that reality in recent years. Some of its most recent brand-new launches, especially the cancer drug Lumakras, ...

In the long-running feud between Regeneron and Amgen around the companies’ competing PCSK9 cholesterol meds, Regeneron has eked out another legal win over its rival. | A federal jury in Delaware ...

Amgen, based in Thousand Oaks, California, first broke ground in New Albany in 2021 on a 270,000 square-foot pharmaceutical packaging facility that opened in February 2024.